Dextromethorphan and Codeine: Objective Assessment of Antitussive Activity in Patients with Chronic Cough

Publisher Website
Google Scholar
Abstract
Dextromethorphan, the most widely used cough suppressant in the U.S.A., was compared with codeine, the traditional European antitussive, in a double-blind, crossover trial using both an objective and subjective assessment of efficacy in sixteen patients with chronic, stable cough. Both preparations, at a dose of 20 mg, were similarly effective in reducing cough frequency. Dextromethorphan lowered cough intensity to a greater degree than codeine (p < 0·0008) and was considered the better antitussive by the majority of patients (p < 0·001). In view of its lack of side-effects, its safety even in overdose and its non-narcotic status, the increasing trend in Europe to use dextromethorphan as a substitute for codeine in the treatment of cough is to be welcomed.

This publication has 2 references indexed in Scilit: